Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Structural and biochemical studies on Pompe disease and a "pseudodeficiency of acid alpha-glucosidase".

Tajima Y, Matsuzawa F, Aikawa S, Okumiya T, Yoshimizu M, Tsukimura T, Ikekita M, Tsujino S, Tsuji A, Edmunds T, Sakuraba H.

J Hum Genet. 2007;52(11):898-906.

PMID:
17805474
2.

Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease).

Raben N, Plotz P, Byrne BJ.

Curr Mol Med. 2002 Mar;2(2):145-66. Review.

PMID:
11949932
3.

Acid alpha-glucosidase deficiency (Pompe disease).

Fukuda T, Roberts A, Plotz PH, Raben N.

Curr Neurol Neurosci Rep. 2007 Jan;7(1):71-7. Review.

PMID:
17217857
4.

Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.

Katzin LW, Amato AA.

J Clin Neuromuscul Dis. 2008 Jun;9(4):421-31. doi: 10.1097/CND.0b013e318176dbe4. Review.

PMID:
18525427
5.

Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.

van der Beek NA, Hagemans ML, van der Ploeg AT, Reuser AJ, van Doorn PA.

Acta Neurol Belg. 2006 Jun;106(2):82-6. Review.

PMID:
16898258
6.

alpha-glucosidase (CHO) (Genzyme).

Lachmann RH.

Curr Opin Investig Drugs. 2004 Oct;5(10):1101-10. Review.

PMID:
15535432
7.

Design and screening strategies for alpha-glucosidase inhibitors based on enzymological information.

Hakamata W, Kurihara M, Okuda H, Nishio T, Oku T.

Curr Top Med Chem. 2009;9(1):3-12. Review.

PMID:
19199993
8.

Sibling phenotype concordance in classical infantile Pompe disease.

Smith WE, Sullivan-Saarela JA, Li JS, Cox GF, Corzo D, Chen YT, Kishnani PS.

Am J Med Genet A. 2007 Nov 1;143A(21):2493-501. Review.

PMID:
17853454
9.

[Pompe's disease. Part I: pathogenesis and clinical features].

Ill├ęs Z, Trauninger A.

Ideggyogy Sz. 2009 Jul 30;62(7-8):231-43. Review. Hungarian.

PMID:
19685701
10.

Successful combined liver/kidney transplantation from a donor with Pompe disease.

Halldorson J, Kazi Z, Mekeel K, Kuo A, Hassanein T, Loomba R, Austin S, Valasek MA, Kishnani P, Hemming AW.

Mol Genet Metab. 2015 Aug;115(4):141-4. doi: 10.1016/j.ymgme.2015.05.007. Review.

PMID:
26031770
11.

[Therapeutic trials for the patients with muscle glycogen storage diseases].

Sugie H.

No To Hattatsu. 2004 Mar;36(2):136-40. Review. Japanese.

PMID:
15031988
12.

5-(4-(4-Acetylphenyl)piperazin-1-ylsulfonyl)indolin-2-one Analogs as Inhibitors of Acid alpha-Glucosidase for Potential Chaperone Treatment of Pompe Disease or Intervention for Diabetes Mellitus Type 2.

Xiao J, Marugan JJ, Zheng W, Motabar O, Southall N, Goldin E, Sidransky E, Liu K, Ferrer M, Austin CP.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2010 Oct 28 [updated 2013 May 3].

13.

Biochemical, structural, and molecular genetic aspects of halophilism.

Eisenberg H, Mevarech M, Zaccai G.

Adv Protein Chem. 1992;43:1-62. Review. No abstract available.

PMID:
1442321

Supplemental Content

Support Center